Procter & Gamble Health Ltd (PGHL) Stock Price & News

PGHL:NSE

Procter & Gamble Health Ltd

5 182,00 INR

-0,35%

(-18,00) 1D

19 ოქტ, 09:55:10 GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for PGHL...

Open

5 204,50 INR

High

5 211,50 INR

Low

5 166,00 INR

Mkt. cap

86,02 მლრდ.

Avg. vol.

11,51 ათ.

Volume

374,00

Dividend

2,99%

Quarterly dividend

38,75 INR

Ex-dividend date

21 აგვ. 2026

P/E ratio

26,58

52-wk high

6 975,00 INR

52-wk low

4 707,00 INR

EPS

194,99 INR

No. of employees

1 ათ.

Open

5 204,50 INR

High

5 211,50 INR

Low

5 166,00 INR

Mkt. cap

86,02 მლრდ.

Avg. vol.

11,51 ათ.

Volume

374,00

Dividend

2,99%

Quarterly dividend

38,75 INR

Ex-dividend date

21 აგვ. 2026

P/E ratio

26,58

52-wk high

6 975,00 INR

52-wk low

4 707,00 INR

EPS

194,99 INR

No. of employees

1 ათ.

Related stocks

STAR

Strides Pharma Science Ltd

1 037,50 INR

-0,74%

SUVEN

Suven Life Sciences Ltd

Sanofi Consumer Healthcare India Ltd

3 520,00 INR

-0,81%

News stories

From web sources and news partners

01net

1 საათის წინ

OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight as the Agentic Foundation for Its Up to $1 Billion Tokenized Solar and AI Computing Program with Meridian and Up to $130 Million IP-Backed Transaction with BeyondAI

TradingView

19 წუთის წინ

No ‘Black Monday’? Nasdaq, S&P 500, Dow Futures Spike As Big Tech Earnings Loom This Week — Retail Stays Cautious

BigGo Finance

21 წუთის წინ

South Korea's FSS Chief Says Solidigm's Nasdaq Listing Would Constitute Duplicate Listing, Hints at Conveying Concerns to SK Hynix

Bloomberg.com

6 საათის წინ

US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap

About Procter & Gamble Health Ltd

CEO-

Employees1,28 ათ.

Founded1967

Headquarters-

SectorPharmaceutical industry

Websitepghealthindia.com

Revenue

Net income

All values in INR	სექ. 2025	დეკ. 2025	მარ. 2026	ივნ. 2026
Revenue	3,25 მლრდ.	3,74 მლრდ.	3,70 მლრდ.	3,64 მლრდ.
Cost of goods sold	684,00 მლნ.	1,10 მლრდ.	1,03 მლრდ.	962,20 მლნ.
Cost of revenue	684,00 მლნ.	1,10 მლრდ.	1,03 მლრდ.	962,20 მლნ.
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	538,80 მლნ.	618,10 მლნ.	1,40 მლრდ.	603,90 მლნ.
Operating expense	1,42 მლრდ.	1,59 მლრდ.	1,36 მლრდ.	1,74 მლრდ.
Total operating expenses	2,11 მლრდ.	2,69 მლრდ.	2,39 მლრდ.	2,70 მლრდ.
Operating income	1,14 მლრდ.	1,05 მლრდ.	1,31 მლრდ.	935,80 მლნ.
Other non operating income	49,50 მლნ.	43,60 მლნ.	-80,60 მლნ.	38,80 მლნ.
EBT including unusual items	1,19 მლრდ.	1,09 მლრდ.	1,33 მლრდ.	1,29 მლრდ.
EBT excluding unusual items	1,19 მლრდ.	1,09 მლრდ.	1,35 მლრდ.	973,20 მლნ.
Income tax expense	304,80 მლნ.	312,30 მლნ.	386,10 მლნ.	329,70 მლნ.
Effective tax rate	25,61%	28,70%	28,98%	25,53%
Other operating expenses	823,70 მლნ.	917,70 მლნ.	-99,20 მლნ.	1,08 მლრდ.
Net income	885,40 მლნ.	775,90 მლნ.	946,00 მლნ.	961,50 მლნ.
Net profit margin	27,25%	20,75%	25,54%	26,44%
Earnings per share	-	-	-	-
Interest and investment income	-	-	105,90 მლნ.	-
Interest expense	-1,20 მლნ.	-1,00 მლნ.	-2,10 მლნ.	-1,40 მლნ.
Net interest expenses	-1,20 მლნ.	-1,00 მლნ.	103,80 მლნ.	-1,40 მლნ.
Depreciation and amortization charges	60,80 მლნ.	59,00 მლნ.	61,70 მლნ.	60,20 მლნ.
EBITDA	1,20 მლრდ.	1,09 მლრდ.	1,36 მლრდ.	994,78 მლნ.
Gain or loss from assets sale	-	-	-	-

Ask anything